Interv Akut Kardiol. 2023;22(2):70-73 | DOI: 10.36290/kar.2023.018
From venous thromboembolism to chronic thromboembolic pulmonary disease
- II. interní klinika kardiologie a angiologie, Centrum pro plicní hypertenzi, Všeobecná fakultní nemocnice a 1. lékařská fakulta UK, Praha
Chronic thromboembolic pulmonary hypertension is a serious complication of acute venous thromboembolism which, if unrecognized and untreated, leads to death. This case report presents the development of pulmonary hypertension in a patient after pulmonary embolism.
Keywords: pulmonary hypertension, pulmonary embolism, CTEPH.
Received: March 10, 2023; Accepted: May 3, 2023; Published: May 9, 2023 Show citation
References
- Konstantinides SV, Meyer G, Becattini C, et al; The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J. 2019 Oct 9;54(3):1901647. doi: 10.1183/13993003.01647-2019. PMID: 31473594.
Go to original source... 
Go to PubMed... - Wendelboe AM, Raskob GE. Global Burden of Thrombosis: Epidemiologic Aspects. Circ Res. 2016 Apr 29;118(9):1340-7. doi: 10.1161/CIRCRESAHA.115.306841. PMID: 27126645. Go to original source... Go to PubMed...
- Gall H, Hoeper MM, Richter MJ, et al. An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan. Eur Respir Rev. 2017 Mar 29;26(143):160121. doi: 10.1183/16000617.0121-2016. PMID: 28356407; PMCID: PMC9488926. Go to original source... Go to PubMed...
- Ende‑Verhaar YM, Cannegieter SC, Vonk Noordegraaf A, et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature. Eur Respir J. 2017 Feb 23;49(2):1601792. doi: 10.1183/13993003.01792-2016. PMID: 28232411. Go to original source... Go to PubMed...
- Pepke‑Zaba J, Delcroix M, Lang I, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011 Nov 1;124(18):1973-81. doi: 10.1161/CIRCULATIONAHA.110.015008. Epub 2011 Oct 3. PMID: 21969018. Go to original source... Go to PubMed...
- Delcroix M, Kerr K, Fedullo P. Chronic Thromboembolic Pulmonary Hypertension. Epidemiology and Risk Factors. Ann Am Thorac Soc. 2016 Jul;13 Suppl 3:S201-6. doi: 10.1513/AnnalsATS.201509-621AS. PMID: 27571001. Go to original source... Go to PubMed...
- Pengo V, Denas G, Zoppellaro G, et al. Rivaroxaban vs warfarin in high‑risk patients with antiphospholipid syndrome. Blood. 2018 Sep 27;132(13):1365-1371. doi: 10.1182/blood-2018-04-848333. Epub 2018 Jul 12. PMID: 30002145. Go to original source... Go to PubMed...
- Ghofrani HA, D'Armini AM, Grimminger F, et al; CHEST-1 Study Group. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013 Jul 25;369(4):319-29. doi: 10.1056/NEJMoa1209657. PMID: 23883377. Go to original source... Go to PubMed...
- Sadushi‑Kolici R, Jansa P, Kopec G, et al. Subcutaneous treprostinil for the treatment of severe non‑operable chronic thromboembolic pulmonary hypertension (CTREPH): a double‑blind, phase 3, randomised controlled trial. Lancet Respir Med. 2019 Mar;7(3):239-248. doi: 10.1016/S2213-2600(18)30367-9. Epub 2018 Nov 23. PMID: 30477763. Go to original source... Go to PubMed...